Last update Nov. 24, 2014
We do not have alternatives for Maternal Hyperprolactinemia.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Maternal Hyperprolactinemia is also known as
Maternal Hyperprolactinemia belongs to this group or family:
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Hyperprolactinemia by itself is not a contraindication while breastfeeding. There is experience about long-lasting breastfeeding from 8 to 33 months long without encountering any problem (even when patients have taken Bromocriptine).
If because an increased level of prolactinemia it would require medication, it is preferred to use Bromocriptine or Lisuride instead of Cabergoline because a lesser storage in blood, lesser passage to breast milk and poor absorption by the infant, even though, they are worst tolerated by the mother.